person

Bartlomiej K.

Country
Poland
Department
Ophtalmology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
92
Sites with multiple studies

Has run more than one trial at 92 of 179 partner sites.

Specializations

Macular Degeneration Research

Specializes in investigating innovative treatments for age-related macular degeneration, with particular emphasis on both wet AMD and geographic atrophy. Conducts research on novel therapeutic approaches including complement inhibition and combination therapies with established treatments.

  • Neovascular (wet) AMD interventions
  • Geographic atrophy treatments
  • Long-term therapeutic solutions

Focuses on evaluating both intravitreal and systemic treatment approaches for macular degeneration conditions.

Diabetic Eye Disease

Investigates therapeutic solutions for diabetic retinal conditions, including advanced treatments for diabetic macular edema and diabetic retinopathy. Explores novel compounds and their effects on visual acuity improvement.

  • Diabetic macular edema management
  • Diabetic retinopathy progression
  • Visual acuity preservation strategies

Evaluates treatment efficacy using standardized assessment tools and long-term outcome measures.

Ophthalmic Therapeutics

Explores innovative ocular drug delivery systems and therapeutic approaches, including intravitreal applications and novel biological compounds. Focuses on comparing new therapeutic agents with established treatments.

  • Intravitreal therapeutic applications
  • Novel biological compounds
  • Comparative treatment efficacy

Specializes in evaluating safety profiles and therapeutic outcomes of experimental eye treatments.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.